N/A N=3,368 JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Primary: Percentage of Participants With Any Adverse Events — 13.93 Percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=33 Strength Training and Endurance Exercise for LIFE
HIV
Primary: Aerobic Capacity — 0.15; 0.02 Liters/minute
N/A N=20 The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
Hypertension · Physical Disability · Aging
Primary: Seated Blood Pressure — 112.1; 116.1; 60.3; 60.4 mmHg
N/A N=61 LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
HIV · Sexually Transmitted Diseases · Risk Reduction
Primary: Acceptability — 75.63 units on a scale
Phase 3 N=954 Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c at Week 52 — -0.40; -0.65; -0.49; -0.61 percentage of HbA1c — p=0.3306
Phase 4 N=11 Varenicline Light Smoking Pilot
Smoking Cessation · Smoking Behaviors · Smoking
Primary: Change in Self-Reported Craving Level Via Lab-Based Cue Reactivity — 6.31; 4.2; 2.56; 2.4 score on a scale
N/A N=40 Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
Upper Respiratory Infection · Acute Otitis Media
Primary: Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil — 4; 1 Samples — p=0.05
Phase 4 N=30 Multi-center Study to Transplant Hepatitis-C Infected Kidneys
Renal Failure Chronic · Hepatitis C
Primary: Number of Participants With Undetectable HCV — 30 Participants
N/A N=23 Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Adult Grade III Lymphomatoid Granulomatosis · B-cell Chronic Lymphocytic Leukemia · Contiguous Stage II Adult Burkitt Lymphoma
Primary: >= 2 Fold Increase in Circulating PBSC's — 0; 4; 3; 13 Participants
N/A N=13 Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder
Major Depressive Disorder · MDD · Depression
Primary: Participant's Desire to Continue Using VR After the Study Ends — 9.54 score on a scale
N/A N=25 Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
Bladder Cancer · Low Testosterone Levels
Primary: Number of Hypogonadism in Participants Based on Serum Testosterone 90 Days Post Radical — 6 participants
Phase 1 N=48 Phase I Study of OPC-61815
Congestive Heart Failure
Primary: Time-matched Difference Between the OPC-61815/Moxifloxacin and Placebo Data in Change From Baseline for QTcF in 12-lead Holter Electrocardiogram (ECG) — 0.9; 0.0; 9.9…
N/A N=59 Behavioral Treatment of Adolescent Substance Use
Substance Use Disorders
Primary: Any Cannabis Abstinence — 13; 18 participants
N/A N=143 Use of Simulation to Improve VAD Self-management
Heart Failure
Primary: Comparisons of VAD-care Checklist Assessment on the Patient and Written Examination Scores Between SBML and Usual Training Groups — 100; 97.1; 100; 100 percentage of…
Phase 3 N=170 A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Hypoglycemia · Diabetes Mellitus, Type 1
Primary: Time to Plasma Glucose Recovery — 10; 40; 12 minutes — p=<0.001